Commonwealth Equity Services’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.1M Sell
13,489
-319
-2% -$179K 0.01% 1155
2026
Q1
$7.76M Buy
13,808
+87
+0.6% +$55.8K 0.01% 1050
2025
Q4
$9.28M Sell
13,721
-3,686
-21% -$2.51M 0.01% 928
2025
Q3
$11.1M Sell
17,407
-898
-5% -$545K 0.01% 866
2025
Q2
$9.82M Buy
18,305
+1,580
+9% +$756K 0.01% 918
2025
Q1
$7.02M Buy
16,725
+251
+2% +$109K 0.01% 1069
2024
Q4
$6.81M Sell
16,474
-1,963
-11% -$861K 0.01% 1046
2024
Q3
$9.31M Sell
18,437
-4,860
-21% -$2.36M 0.01% 862
2024
Q2
$11.4M Sell
23,297
-3,937
-14% -$1.98M 0.02% 743
2024
Q1
$14.7M Buy
27,234
+3,571
+15% +$1.95M 0.02% 617
2023
Q4
$13.1M Buy
23,663
+286
+1% +$134K 0.02% 607
2023
Q3
$10.2M Buy
23,377
+5
+0% +$2.49K 0.02% 663
2023
Q2
$11.7M Sell
23,372
-772
-3% -$370K 0.02% 612
2023
Q1
$12.1K Buy
24,144
+601
+3% +$288K 0.03% 582
2022
Q4
$9.6M Sell
23,543
-471
-2% -$183K 0.02% 643
2022
Q3
$7.82M Sell
24,014
-130
-0.5% -$47.8K 0.02% 680
2022
Q2
$8.47M Sell
24,144
-617
-2% -$252K 0.02% 649
2022
Q1
$13.5M Buy
24,761
+182
+0.7% +$95.7K 0.03% 496
2021
Q4
$16.2M Buy
24,579
+1,218
+5% +$765K 0.04% 436
2021
Q3
$14.5M Buy
23,361
+8
+0% +$5.38K 0.04% 437
2021
Q2
$14.7M Buy
23,353
+123
+0.5% +$67.9K 0.04% 440
2021
Q1
$11.4M Sell
23,230
-653
-3% -$327K 0.03% 476
2020
Q4
$11.9M Sell
23,883
-1,665
-7% -$745K 0.04% 424
2020
Q3
$10M Buy
25,548
+502
+2% +$186K 0.03% 433
2020
Q2
$8.27M Buy
25,046
+663
+3% +$192K 0.03% 463
2020
Q1
$5.91M Sell
24,383
-4,204
-15% -$1.1M 0.03% 497
2019
Q4
$7.46M Buy
28,587
+1,220
+4% +$321K 0.03% 491
2019
Q3
$7.44M Buy
27,367
+1,095
+4% +$305K 0.03% 471
2019
Q2
$7.23M Sell
26,272
-348
-1% -$85.7K 0.03% 459
2019
Q1
$5.95M Buy
26,620
+836
+3% +$173K 0.03% 508
2018
Q4
$4.8M Buy
25,784
+3,572
+16% +$732K 0.03% 511
2018
Q3
$5.54M Buy
22,212
+1,037
+5% +$252K 0.03% 505
2018
Q2
$4.62M Sell
21,175
-497
-2% -$102K 0.02% 535
2018
Q1
$4.15M Buy
21,672
+2,970
+16% +$548K 0.02% 541
2017
Q4
$2.92M Buy
18,702
+445
+2% +$70K 0.02% 662
2017
Q3
$2.84M Sell
18,257
-1,434
-7% -$227K 0.02% 638
2017
Q2
$3.18M Buy
19,691
+2,530
+15% +$411K 0.02% 576
2017
Q1
$2.65M Buy
17,161
+2,103
+14% +$290K 0.02% 626
2016
Q4
$1.77M Sell
15,058
-2,810
-16% -$321K 0.01% 763
2016
Q3
$2.01M Sell
17,868
-1,174
-6% -$124K 0.02% 680
2016
Q2
$1.77M Sell
19,042
-384
-2% -$33K 0.01% 707
2016
Q1
$1.52M Buy
19,426
+770
+4% +$55.4K 0.01% 757
2015
Q4
$1.36M Sell
18,656
-44
-0.2% -$3.14K 0.01% 765
2015
Q3
$1.39M Buy
18,700
+2,441
+15% +$175K 0.01% 743
2015
Q2
$1.04M Buy
16,259
+1,373
+9% +$95K 0.01% 931
2015
Q1
$1.15M Buy
14,886
+1,544
+12% +$120K 0.01% 878
2014
Q4
$989K Buy
13,342
+2,104
+19% +$148K 0.01% 902
2014
Q3
$662K Buy
11,238
+926
+9% +$58.5K 0.01% 1072
2014
Q2
$689K Buy
10,312
+2,738
+36% +$174K 0.01% 1064
2014
Q1
$460K Sell
7,574
-8
-0.1% -$477 0.01% 1223
2013
Q4
$403K Sell
7,582
-82
-1% -$4.32K 0.01% 1263
2013
Q3
$382K Sell
7,664
-46
-0.6% -$2.21K 0.01% 1225
2013
Q2
$346K Buy
+7,710
New +$337K 0.01% 1220

Other funds holding IDXX

Commonwealth Equity Services's IDXX Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Idexx Laboratories (IDXX) stake by 2.3% in Q2 2026, selling an estimated $179K and leaving 13,489 shares worth $7.1M. The position accounts for 0.01% of the portfolio, ranked #1155.

Commonwealth Equity Services first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.2M in Q4 2021. 461 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Commonwealth Equity Services held 13,489 shares of Idexx Laboratories worth $7.1M as of Q2 2026.
  • Commonwealth Equity Services sold 319 Idexx Laboratories shares in Q2 2026, an estimated $179K.
  • Idexx Laboratories made up 0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #1155 holding.
  • Commonwealth Equity Services first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Commonwealth Equity Services's Idexx Laboratories position peaked at $16.2M in Q4 2021.
  • 461 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.